1-5 of 5
Frank Claessens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer

Justine Habault, Jeffrey A. Schneider, Susan Ha, Rachel Ruoff, Luiza D. Pereira, Joseph Puccini, Michela Ranieri, Ruveyda Ayasun, Jiehui Deng, Amanda C. Kasper, Dafna Bar-Sagi, Kwok-Kin Wong, Amina Zoubeidi, Frank Claessens, David R. Wise, Susan K. Logan, Kent Kirshenbaum, Michael J. Garabedian
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (10): 1166–1181.
https://doi.org/10.1158/1535-7163.MCT-23-0196
Published: 02 October 2023
View article titled, A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer
Open the PDF for A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors

Christine Helsen, Tien T. Nguyen, Xiao Yin Lee, Roy Eerlings, Nikolaos Louros, Joost Schymkowitz, Frederic Rousseau, Frank Claessens, Arnout Voet
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (12): 1823–1834.
https://doi.org/10.1158/1535-7163.MCT-22-0340
Published: 02 December 2022
View article titled, Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors
Open the PDF for Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors in another window
Includes: Supplementary data
Journal Articles

The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models

Florian Handle, Martin Puhr, Georg Schaefer, Nicla Lorito, Julia Hoefer, Martina Gruber, Fabian Guggenberger, Frédéric R. Santer, Rute B. Marques, Wytske M. van Weerden, Frank Claessens, Holger H.H. Erb, Zoran Culig
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2018) 17 (12): 2722–2731.
https://doi.org/10.1158/1535-7163.MCT-18-0508
Published: 03 December 2018
View article titled, The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
Open the PDF for The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models in another window
Includes: Supplementary data
Journal Articles

The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide

Stefan Prekovic, Martin E. van Royen, Arnout R.D. Voet, Bart Geverts, Rene Houtman, Diana Melchers, Kam Y.J. Zhang, Thomas Van den Broeck, Elien Smeets, Lien Spans, Adriaan B. Houtsmuller, Steven Joniau, Frank Claessens, Christine Helsen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (7): 1702–1712.
https://doi.org/10.1158/1535-7163.MCT-15-0892
Published: 05 July 2016
View article titled, The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide
Open the PDF for The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide in another window
Includes: Supplementary data
Journal Articles

Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth

Christine Helsen, Arnaud Marchand, Patrick Chaltin, Sebastian Munck, Arnout Voet, Annemieke Verstuyf, Frank Claessens
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (6): 1257–1268.
https://doi.org/10.1158/1535-7163.MCT-11-0763
Published: 10 June 2012
View article titled, Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth
Open the PDF for Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth in another window
Includes: Supplementary data